Hoffmann-La Roche Inc. agreed to spend upward of $215 million in a global partnership with Isotechnika Inc. to develop a transplantation drug with blockbuster potential. (BioWorld Today)

XOMA Ltd.’s stock took a painful hit Friday when the company and its partner, Genentech Inc., released poor preliminary data from a pharmacokinetic study of Xanelim, a psoriasis drug. (BioWorld Today)

XOMA Ltd.’s stock took a painful hit Friday when the company and its partner, Genentech Inc., released poor preliminary data from a pharmacokinetic study of Xanelim, a psoriasis drug. (BioWorld Today)

CancerVax Corp., a young company studying a vaccine for melanoma and colon cancer, on Monday said it raised $55 million in its second round of financing through the private placement of preferred stock. (BioWorld Today)

CancerVax Corp., a young company studying a vaccine for melanoma and colon cancer, on Monday said it raised $55 million in its second round of financing through the private placement of preferred stock. (BioWorld Today)